e-CRFs mean speedier reviews

Posted:
25
August 2003

We have established a new web-based system for online data entry of our CRFs (Case Report Forms).

We are using conventional paper CRFs (so there is no worry for clients) which are then remotely entered into a database enabling us to produce tables and listings for safety review within two days of dosing. This is particularly useful in dose escalation studies as meaningful safety reviews can be developed within a very effective time frame.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more